Clinical trial

Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer

NCT04761055

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-01-29

PhaseNA

Study timeline

Study start (actual)2021-01-29Date precision: day

Registry last updated2026-07-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Screeningunresolved

Interventions

Clinical Breast exam (CBE)OTHER

iBreastExam deviceDEVICE

mammogramDIAGNOSTIC_TEST

Sponsors & collaborators

Memorial Sloan Kettering Cancer Centerlead sponsor

UE LifeSciences Inc.collaborator

Earlier.orgcollaborator

Mapped research locations

New YorkNew York, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04761055 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.